Delcath Systems, Inc.
Ticker Symbol: USOTC:DCTH
OTC Market Tier: OTCQB
CIK Number: 0000872912
Security Type: Common Stock
DCTH Address: 1633 Broadway
Suite 22C
New York, New York 10019
DCTH Country: USA
DCTH Phone: (212) 489-2100
DCTH Fax #: N/A
Description: Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology.
SIC Code / Description: 3841 / Surgical and medical instruments
Shares Authorized: 1,000,000,000
Shares Outstanding: 18,277,807
Shares Outstanding Date: 10/08/2019
Shares Holder Count: 40
Shares Holder Date: 07/18/2019
Market Capitalization: $ 1,755,583.36
Key Executives: William Rueckert - Dir.
Marco Taglietti - Dir.
Janetta Trochimiuk - Controller
Jennifer Simpson - CEO
John Purpura - EVP, Ops.
Barbra Keck - CFO
John Sylvester - Dir.
Roger Stoll - Chairman
Number of Employees: N/A
Incorporation State: DE
Incorporation Country: USA
Incorporation Year: 1988
Auditor: Marcum LLP
Auditor Address: 750 Third Ave
11th Floor
New York, NY 10017
United States
Auditor Website:
IR Firm: N/A
Legal Counsel: McCarter & English, LLP
Legal Counsel Address: 100 Mulberry Street
100 Mulberry Street
Newark, NJ 07102
Legal Counsel Website: N/A
Fiscal Year End: 12/31
Reporting Status: SEC Reporting
Bankrupt: No
Shell: No
Audit Status: Yes
ADR Ratio: N/A
Transfer Agent: American Stock Transfer & Trust Company
TA Address: 6201 15th Avenue
Brooklyn, NY 11219
Depository Website: N/A
SHO Flag: N/A
3210 Flag: N/A
Short Volume: 658,435
Short Date: 09/13/2019
Closing MMID: 11
BFCMmid: 8
Tier ID: 10
Status: Active

Your Recent History
Delcath Sy..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.